News | August 03, 2023
Jagsonpal Pharmaceuticals posts Q1 FY2024 PAT at Rs. 7.47 Cr
The company has reported total income of Rs. 62.15 crores during the period ended June 30, 2023
The company has reported total income of Rs. 62.15 crores during the period ended June 30, 2023
The company achieved 100% capacity utilisation in the division. These accomplishments stand as a testament to the company's dedication and vision
Proposed acquisition represents meaningful step forward in Biogen’s strategy for sustainable growth
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
Pfizer will make upfront and milestone payments, as well as pay royalties on sales of resulting therapeutics
The agreement extends the customer's suite of cloud DevOps, data engineering, and data platform management solutions
This four-day course is designed for professionals in the pharmaceutical, nutraceutical, and related industries
The 'A+' rating reflects IOL's robust business model, diversified product portfolio
Alembic has a cumulative total of 184 ANDA approvals (159 final approvals and 25 tentative approvals) from USFDA.
This innovative product eliminates two manufacturing steps and simplifies equipment setup
Subscribe To Our Newsletter & Stay Updated
